India, July 31 -- The Government of India has issued a release:
S. No.
State
Component
Govt./Pvt./PSU
Particulars
Total amount Sanctioned/
Amount Released in previous years
Amount Released in 2025-26
1.
Arunachal Pradesh
Strengthening and up-gradation of Ayush Pharmacies and Drug Testing Laboratories to achieve higher standards
Govt.
State Govt. DTL
53,24,026
2023-24:
17,99,813
2.
Mizoram
Govt.
State Govt. DTL
1,60,61,384
2021-22:
18,00,000
3.
Madhya Pradesh
Govt.
State Govt. DTL
75,83,262
-
75,83,262
State
Project Title
Andhra Pradesh
Development of drug master file and technical dossiers on selected single botanicals used in Ayurveda
Development of Technical dossier of Trigonella Foenum graecum - Stage I (preclinical studies- oral toxicity, genotoxicity, efficacy, Pharmacokinetic studies and safety pharmacology in rodents)
Gujarat
Development of Technical dossier of Zingiber Officinale- Stage I (preclinical studies- oral toxicity, genotoxicity, efficacy, Pharmacokinetic studies and safety pharmacology in rodents
Karnataka
Development of Technical dossier of Bacopa monnieri- Stage I (preclinical studies- oral toxicity, genotoxicity, efficacy, Pharmacokinetic studies and safety pharmacology in rodents)
Karnataka
Investigation of potential leads from Ayurveda therapeutics for management of Antimicrobial Resistance (AMR)
Madhya Pradesh
Preclinical Toxicological Evaluation and Safety Pharmacology of Selected Ayurvedic Formulations Triphala churna, Lashunadi vati, and Brihat Vata Chintamani Rasa
Maharashtra
Development of Technical dossier of Boswellia serrata- Stage I (preclinical studies- oral toxicity, genotoxicity, efficacy, Pharmacokinetic studies and safety pharmacology in rodents
Maharashtra
Preclinical Toxicological Evaluation and Safety Pharmacology of Selected Ayurvedic Formulations - Laksha Guggulu, Dadimadi Ghrita and Ekangaveera Rasa
Uttar Pradesh
Development of Technical dossier of Withania somnifera - Stage I (preclinical studies- oral toxicity, genotoxicity, efficacy, Pharmacokinetic studies and safety pharmacology in rodents)
West Bengal
Preclinical Toxicological Evaluation and Safety Pharmacology of Rajah Pravartini Vati, Phala Ghrita and Drakshavaleha
Toxicological Evaluation, Safety Assessment, and Metabolomic Profiling of Selected Ayurvedic drugs and Formulations
Allocated
17,99,813
18,00,000
2024-25:
2023-24:
17,24,400
67,20,884
The Ayush Quality Mark, launched on 19th December, 2025 during the 2nd World Health Organization (WHO) Global Summit on Traditional Medicine, act as a unified quality assurance framework to promote globally accepted standards for Ayush products and services. The implementation of the initiative has been entrusted to AYUSHEXCIL, which is an Ayush Export Promotion Council notified by Directorate General of Foreign Trade (DGFT), Ministry of Commerce and supported by Ministry of Ayush. The Ayush Quality Mark covers Ayush products, Ayush hospitals, day-care centres, clinics, wellness centres, Medical Value Travel Facilitators (MVTFs) and Ayush product testing laboratories. The framework is aligned with internationally accepted standards of quality, safety and efficacy and is supported through accredited certification. The initiative is further complemented by ongoing measures under the Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY) for strengthening quality control infrastructure, regulatory capacity, pharmacovigilance and standardisation.
2024-25:
Ministry of Ayush has implemented a Central Sector Scheme, namely Ayush Oushadhi Gunavatta evam Uttpadan Samvardhan Yojana (AOGUSY), which was approved by Standing Finance Committee (SFC) on 16.03.2021. The total budget allocation to this scheme is Rs.122.00 crores for five years.
57,40,500
During financial year 2025-26, 03 State Drug Testing Laboratories (DTLs) have been supported financially under the AOGUSY scheme. The details of the total amount of funds allocated and released for upgrading drug testing laboratories under AOGUSY during 2025-26 are annexed at Annexure-I.
Certificate of Pharmaceutical Product (CoPP) as per World Health Organization (WHO) guidelines has been extended to Ayurveda, Siddha and Unani (ASU) medicines to strengthen regulatory measures ensuring safety and quality of Ayush drugs. Under the WHO Certification Scheme on the quality of Pharmaceutical Products moving in International Commerce, the Central Drugs Standard Control Organization (CDSCO) issues CoPP for ASU drugs intended for export. The CoPP is issued for the purpose of product registration in importing countries and is based on a joint inspection conducted by representatives of CDSCO, Ministry of Ayush, and the respective Licensing Authority, in accordance with the applicable guidelines and regulatory requirements as per WHO Technical Report Series (TRS).
Ministry of Ayush is implementing the AYURGYAN Scheme, a Central Sector Scheme, under which the Ayurveda Biology Integrated Health Research (ABIHR) has been introduced as the third component to support collaborative, evidence-based research integrating Ayurveda with modern science. The component aims to promote scientific validation of Ayurvedic principles and interventions through preclinical and clinical research, strengthen research capacity, and foster inter-institutional collaborations across the country. Till date, 11 research projects have been sanctioned under the ABIHR component. The details are annexed at Annexure-II.
Ministry of Ayush has not received any proposal for extending these Research and Development (R&D) initiatives or research infrastructure to academic institutions from Odisha including Kandhamal. Therefore, no such proposal is under consideration for setting up specialised Ayush research units in Odisha.
Ministry of Ayush has taken following steps to strengthen the quality assurance, testing and global acceptance of Ayush drugs/medicines in the country:
Annexure-I
The details of total amount of funds allocated and released for upgrading drug testing laboratories (DTLs) under AOGUSY during 2025-26 are as follows:
(Amount in Rs.)
Annexure-II
State-wise details of ongoing research projects under ABIHR component, Ayurgyan Scheme, Ministry of Ayush:
This information was given by Union Minister of State (I/C) for Ayush, Shri Prataprao Jadhav, in a written reply in Lok Sabha today.
Disclaimer: Curated by HT Syndication.
